A detailed history of Act Capital Management, LLC transactions in Oyster Point Pharma, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 8,500 shares of OYST stock, worth $0. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,500
Previous 8,500 -0.0%
Holding current value
$0
Previous $37,000 29.73%
% of portfolio
0.07%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$3.6 - $11.2 $18,000 - $56,000
-5,000 Reduced 37.04%
8,500 $37,000
Q4 2021

Feb 03, 2022

SELL
$10.17 - $18.96 $183,060 - $341,280
-18,000 Reduced 57.14%
13,500 $247,000
Q2 2021

Aug 16, 2021

BUY
$16.25 - $21.51 $511,875 - $677,565
31,500 New
31,500 $542,000

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.